| http://www.w3.org/ns/prov#value | - Seattle, WA (PRWEB) May 04, 2015 ... of a collaboration to facilitate development of NM108, a ... disorders that lead to blindness, including Diabetic Retinopathy. ... formulation platform developed by EyeCRO, which can deliver drugs ... a topical eyedrop. , Under the terms of ... (Date:5/4/2015)...
|
